Old Foundations in a New Era of Myasthenia Gravis Therapy

Kara Stavros: Dr. Stavros has served as a paid consultant for Springer Healthcare. Pushpa Narayanaswami: Research Support: NIH, Alexion, Argenx, Cabaletta-Bio, Dianthus. Advisory boards/Consultation: Alexion, Argenx, Amgen, CVS, Cartesian, Dianthus, EMD-Serono, GSK, Immunovant, Immune-Abs, Janssen, Novartis, UCB, Vor-Bio. Speaker honoraria: UCB, Alexion, WebMD, PeerVoice, Medscape, Academic CME, Med Learning Group. Data Safety Monitoring Boards: Alexion, NMD pharma, Sanofi. Royalties: Springer Nature. Other: Serve as Associate Editor, Muscle and Nerve and Associate Editor, Classification of Evidence, Neurology. The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.